OptiHepan

OptiHepan

Each packet (5g) of OptiHepan oral solution contains 3g of L-ornithine L-aspartate. The drug is used to support the treatment of chronic liver diseases such as hepatitis, cirrhosis, liver diseases related to viral infections, liver damage due to toxicity, or infectious liver diseases…

Category:

Description

Ingredient

Active ingredient Content/packet: 5g
L-ornithine L-aspartate 3 g

Assign

It assists in the treatment of chronic liver diseases such as hepatitis, cirrhosis, liver diseases related to viral infections, liver damage due to toxicity, or other toxic liver diseases.

Instructions for use, dosage

Instructions for use:
For oral use.
Dissolve the medicine in the packet in 1 cup of water, stirring until completely dissolved.

Dosage:
Typical dose: 1 or 2 packets/dose, maximum 3 times/day.
If there is no improvement or the condition worsens after 4 weeks of use, inform your doctor.

Contraindications

Patients who are hypersensitive to L-ornithine L-aspartate or any of the excipients of the drug.
Patients with severe renal impairment (serum creatinine levels > 3 mg/100ml)
Patients with metabolic disorders of amino acids involved in the urea cycle, such as those with enzyme deficiencies.

Use of medication for pregnant and breastfeeding women

Pregnant women
There are no clinical data on the use of L-ornithine L-aspaginate during pregnancy. There are insufficient animal studies on the effects of L-ornithine L-aspartate on fertility, therefore its use should be avoided during pregnancy. However, if the use of medication during pregnancy is necessary, the risks and benefits of treatment should be weighed.

Breastfeeding women
There is no known data on whether L-ornithine L-aspartate is excreted into breast milk. Avoid using medication while breastfeeding. However, if the use of medication during breastfeeding is necessary, the risks and benefits of treatment should be weighed.

Affects fertility
There are no clinical data studying the effects of L-ornithine L-aspartate on fertility.

The effects of medication on the ability to drive and operate machinery

The ability to drive and operate machinery may be impaired due to the medical condition of patients being treated with OptiHepan.

Packaging specifications

Box of 30 packets.
The medicine is packaged in 3-layer packets (paper/aluminum/PE), each packet containing 5 g of rice flakes for oral solution.

Storage conditions

Store at a temperature below 30°C, away from moisture.

Reviews

There are no reviews yet.

Be the first to review “OptiHepan”

Welcome to WordPress. This is your first post. Edit or delete it, then start writing! Required fields are marked *